GROWTH + TRANSITIONAL CAPITAL

We offer profitable, closely-held technology companies, with less than $10 million in revenue, the capital and operational guidance to break through current revenue ceilings.

View our Company Focus »

Apogee

Apogee Informatics Corporation becomes Main Line Equity Partners' seventh portfolio company. Led by President and CEO Andy Laidig, Apogee delivers niche technology to healthcare organizations throughout the United States by changing the way patient information and resources are managed—real time views, retrospective analysis, and simulation forecasting.

Main Line Equity Partners' investment in Apogee supports a growth strategy that will rapidly increase software users through indirect sales channels and partnerships with tier one healthcare platforms.

×

C2 Therapeutics

Main Line Equity Partners made an investment in C2 Therapeutics, a privately held company that improves the treatment of precursors to esophageal cancer (known as Barrett’s Esophagus). The financing will help C2 expand the development of its Coldplay Focal Cryoballoon Ablation System—innovative technology that sets a new standard for simplicity in ablation of Barrett's Esophagus. Barrett's Esophagus is a result of chronic injury from gastroesophageal reflux disease. Over time, the normal esophageal lining is replaced with abnormal cells, putting patients at greater risk of cancer. C2 received a Section 510(k) clearance from the FDA to market its Coldplay Cryoballon Focal Ablation System.

×

Cianflone Scientific Instruments Corp.

In 2015, Main Line Equity Partners acquired Pittsburgh-based Cianflone Scientific Instruments Corporation with a growth strategy to significantly expand its portable x-ray spectrographs designed for on-site chemical analysis and coating thickness measurements. Cianflone was founded in 1984 and has over 500 customers worldwide. Main Line Equity Partners' Operating Partner Doug Hart explains, "Cianflone has built a solid, credible reputation for their niche products. This acquisition presents an opportunity for Cianflone to capitalize on future and existing business opportunities."

×

Clutch

Adding to its portfolio of emerging technology companies, Main Line Equity Partners invested in Clutch, a Mobile Commerce Platform and App that unites shopping, loyalty, and gifting.

Clutch delivers relevant offers to consumers and targeted customers to merchants. Its consumer-facing App "eliminates the need for multiple Apps, enabling consumers to manage gift and loyalty cards, daily deals, coupons, offer searches, purchases, shopping comparisons, social gifting, and mobile payments all in one place," explains Clutch CEO Ned Moore.

×

Converge HR Solutions

In 2015, Main Line Equity Partners teamed with Mark Izzo, founder and principal at Converge HR Solutions, to help fund key business operations needed to position the company for significant strategic growth. Alongside the investment, Main Line Equity Partners is providing leadership and operational resources needed to align with Converge for the future.

×

InfoMC

In February 2014, InfoMC, the leading provider of clinical and financial management software for chronic illness care coordination and wellness, completed an investment by Main Line Equity Partners.

The financing will help InfoMC expand its suite of products available to commercial and public sector healthcare organizations on-premise and in the Cloud. To improve the quality, cost, and value of healthcare, InfoMC's member centric approach uses collaborative process management technology and integrated solutions to enhance the interaction between payors, providers, and consumers. "The team at Main Line Equity Partners is invested in our on business strategically by also bringing their knowledge of the healthcare industry combined with expertise growing technology portfolio companies," said JJ Farook, Chairman and CEO of InfoMC. "We are very excited to take InfoMC to the next level."

Read the Press Release

×

Hemoshear

A 2012 investment, HemoShear creates human relevant systems that accurately replicate the biology of organ systems and diseases throughout drug discovery and development.

To understand biological and pharmacological responses in humans, HemoShear conducts experimental programs using human primary cells and creates systems that restore cells to an in vivo environment for healthy or disease conditions of interest. Their validated human systems can be adapted to answer complex questions at any stage in drug discovery and development.

×

Matrix Solutions

In July 2013, Main Line Equity Partners invested in Matrix Solutions. Matrix helps manage and analyze media sales with its industry-leading CRM and sales analytics platform—transforming data into actionable information to help account executives and managers increase sales across TV, Radio, and electronic advertising businesses.

"Matrix has a proven technology platform and an outstanding team with extensive knowledge in the media industry. The Company is extremely customer focused through not just the products it offers, but how the service is delivered; likely why they have a 90% renewal rate on three-year contracts. We are extremely excited that our combined efforts will result in enhanced products and services to existing and future clients," said Mark Gorman, Managing Director at Main Line Equity Partners.

Read the Press Release

×

Portico

Acquired by McKesson in June 2011, Portico Systems' Integrated Provider Management (IPM) Platform empowers health plans to transform the performance management of their provider networks, while significantly reducing medical, administrative and IT costs.

The IPM Platform also simplifies the design, maintenance, and reimbursement of provider networks, while facilitating provider-patient collaboration. Typical results include a 25-35% administrative cost reduction, a 10-20% provider satisfaction increase, and a 1-5% improvement in network performance.

×

Sapheon

Main Line Equity Partners has invested in Sapheon, a medical device company that develops new approaches and disruptive technologies for the treatment of vascular disease. The company's current focus is the VenaSeal Sapheon Closure System, a novel treatment for venous reflux disease.

With full EU regulatory approval already in place, this game-changing approach to treating veins is poised to disrupt a $1 billion worldwide market. The VenaSeal System uses a proprietary medical adhesive to close the saphenous vein, eliminating the need for surgery, ablation, anesthesia, or the use of harsh chemicals. Sapheon is actively preparing for U.S. clinical trials and FDA approval of the VenaSeal Sapheon Closure System.

×

Tensitron

Main Line Equity Partners completed the acquisition of Tensitron, Inc., a global industry leader in the design and manufacturing of digital, mechanical, and electronic tension measuring instrumentation. The acquisition, which includes all assets of Tensitron, will provide the company with capital and human resources to achieve the next step function of growth. Tensitron was founded in 1935 by Dr. Erwin J. Saxl, a well-known physicist. The company quickly became recognized as an industry standard for tension meters and measurement. Prior to the acquisition, Stanley Saxl, son of Erwin, held the role President and was also an innovative developer. Stanley Saxl will step away from Tensitron. Main Line Equity Partners’ Operating Partner Doug Hart will become the new President of Tensitron to manage the business and execute key sales and marketing strategies needed to accelerate Tensitron’s growth. Main Line Equity Partners acquired Cianflone Scientific in 2015 as its first investment in test and measurement technologies. The Tensitron brand, team, and traditional operations will remain the same.

×

SmarterServices

Main Line Equity Partners made an investment in SmarterServices, a provider of data-driven e-learning tools for educational institutions—K-12 schools, colleges, and universities. Online learning, also known as e-learning, is booming. Market research firm Global Industry Analysts projects that e-learning will reach $107 Billion in 2015. Alongside the capital investment, Main Line Equity Partners is providing leadership, operational support, and a strategic growth plan to help SmarterServices executives and their product teams be poised for taking the company to the next level. SmarterServices’ flagship product, SmarterMeasure™, is an online readiness indicator which quantifies a learner’s level of readiness to study online and/or in a technology rich environment. The newest product, SmarterProctoring™, is an exam proctoring management system that allows schools to manage all aspects of proctoring for students—from locating a proctor and scheduling exams to tracking communications and releasing the exams all within the singe solution. Since its product launch in September 2014, SmarterProctoring is being used by more than 25 schools.

×

Webhooks.io

In January 2016, Main Line Equity Partners completed a technology investment for portfolio company SmarterServices to utilize the analytic capabilities of Webhooks.io within its data-driven eLearning applications for educational institutions. Webhooks.io provides a webhook delivery and analytics platform that easily publishes and consumes data in real-time across the Internet by using existing and standardized HTTP methods.

Read the Press Release

×

Wolverton & Co.

In 2010, Main Line Equity Partners joined president William W. Wolverton as a strategic investor to launch and rapidly grow two divisions for the real estate brokerage — Real Estate Sales and Property Management.

Wolverton & Co. previously led Long & Foster's property management division in Haverford PA. Main Line Equity Partners combines its expertise and resources to support Wolverton with go-to-market planning, sales/marketing, agent recruiting, operations, finance, and legal support.

×

Portfolio

Webhooks Logo

Tension Measuring Instrumentation

Location: Longmont, CO

Investment Date: Mar 2016

Tensitron

Main Line Equity Partners made its second investment in test and measurement technologies with Tensitron, who became recognized as an industry standard starting in 1935... read more

Webhooks Logo

Technology Investment for SmarterServices

Location: Birmingham, AL

Investment Date: Jan 2016

Webhooks.io

In January 2016, Main Line Equity Partners completed a technology investment for portfolio company SmarterServices to utilize the analytic capabilities of Webhooks.io within its data-driven eLearning applications for educational institutions... read more

SmarterServices Logo

E-learning Tools for Educational Institutions

Location: Birmingham, AL

Investment Date: May 2015

SmarterServices

Main Line Equity Partners made an investment in SmarterServices, a provider of data-driven e-learning tools for educational institutions—K-12 schools, colleges, and universities. Online learning, also known as e-learning, is booming... read more

Cianflone Logo

Manufacturer of Portable X-ray Spectrographs

Location: Pittsburgh, PA

Investment Date: April 2015

Cianflone Scientific Instruments Corp.

In 2015, Main Line Equity Partners acquired Pittsburgh-based Cianflone Scientific Instruments Corporation with a growth strategy to significantly expand its portable x-ray spectrographs... read more

Converge Logo

Strategic Human Resources Partner & Consulting Firm

Location: Wayne, PA

Investment Date: March 2015

Converge HR Solutions

In 2015, Main Line Equity Partners teamed with Mark Izzo, founder and principal at Converge HR Solutions, to help fund key business operations needed to position the company for significant strategic growth... read more

C2 Logo

Treatment of Precursors to Esophageal Cancer

Location: Redwood City, CA

Investment Date: October 2014

C2 Therapeutics

Main Line Equity Partners made an investment in C2 Therapeutics, a privately held company that improves the treatment of precursors to esophageal cancer (known as Barrett’s Esophagus)... read more

Clinical and Financial Management Software

Location: Conshohocken, PA

Investment Date: February 2014

InfoMC

The financing will help InfoMC expand its suite of products available to commercial and public sector healthcare organizations on-premise and in the Cloud. To improve the quality, cost, and value of healthcare, InfoMC's member centric approach uses collaborative process management technology... read more

Sapheon Logo

Medical Device Company

Location: Morrisville, NC

Investment Date: September 2013

Sapheon

Main Line Equity Partners has invested in Sapheon, a medical device company that develops new approaches and disruptive technologies for the treatment of vascular disease. The company's current focus is the VenaSeal Sapheon Closure System, a novel treatment for venous... read more

Matrix Logo

Media CRM and Sales Analytics Platform

Location: Pittsburgh, PA

Investment Date: July 2013

Matrix Solutions

In July 2013, Main Line Equity Partners invested in Matrix Solutions. Matrix helps manage and analyze media sales with its industry-leading CRM and sales analytics platform—transforming data into actionable information to help account executives and managers increase sales across TV, Radio... read more

Clutch Logo

Mobile Commerce Platform

Location: Landsdale, PA

Investment Date: April 2013

Clutch

Adding to its portfolio of emerging technology companies, Main Line Equity Partners invested in Clutch, a Mobile Commerce Platform and App that unites shopping, loyalty, and gifting... read more

Hemoshear Logo

Biotechnology Research Company

Location: Charlottesville, VA

Investment Date: September 2012

Hemoshear

A 2012 investment, HemoShear creates human relevant systems that accurately replicate the biology of organ systems and diseases throughout drug discovery and development... read more

Apogee Logo

Healthcare Resource Management Software

Location: Madison, AL

Investment Date: May 2012

Apogee Informatics

Apogee Informatics Corporation becomes Main Line Equity Partners' seventh portfolio company. Led by President and CEO Andy Laidig, Apogee delivers niche technology to healthcare organizations throughout the United States by changing the way patient information and resources are managed... read more

Portico Logo

Healthcare Network Management Software

Location: Blue Bell, PA

Investment Date: June 2011

Portico

Acquired by McKesson in June 2011, Portico Systems' Integrated Provider Management (IPM) Platform empowers health plans to transform the performance management of their provider networks, while significantly reducing medical, administrative and IT costs... read more

Wolverton Logo

National, Technology-Focused Real Estate Broker

Location: Narberth, PA

Investment Date: October 2010

Wolverton & Co.

In 2010, Main Line Equity Partners joined president William W. Wolverton as a strategic investor to launch and rapidly grow two divisions for the real estate brokerage — Real Estate Sales and Property Management... read more